A Long-Acting Human Growth Hormone With Delayed Clearance (VRS-317): Results of a Double-Blind, Placebo-Controlled, Single Ascending Dose Study in Growth Hormone–Deficient Adults

BACKGROUND: Administration of daily recombinant human GH (rhGH) poses a considerable challenge to patient compliance. Reduced dosing frequency may improve treatment adherence and potentially overall treatment outcomes. OBJECTIVES: This study assessed the safety and tolerability and the potential for...

Descripción completa

Detalles Bibliográficos
Autores principales: Yuen, Kevin C. J., Conway, Gerard S., Popovic, Vera, Merriam, George R., Bailey, Timothy, Hamrahian, Amir H., Biller, Beverly M. K., Kipnes, Mark, Moore, Jerome A., Humphriss, Eric, Bright, George M., Cleland, Jeffrey L.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Endocrine Society 2013
Materias:
Endocrine Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3667252/
https://www.ncbi.nlm.nih.gov/pubmed/23585663
http://dx.doi.org/10.1210/jc.2013-1437

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3667252/
https://www.ncbi.nlm.nih.gov/pubmed/23585663
http://dx.doi.org/10.1210/jc.2013-1437

Ejemplares similares